Abstract
Worldwide more than 350,000 patients will be diagnosed with oral cancer this year; however, the survival of patients with oral cancer has not changed significantly over the last 30 years. Recent reports have demonstrated that epithelial-mesenchymal transition (EMT) not only contributes to cancer cell invasion and metastasis but it is also associated with treatment resistance. In this review, we will examine the data demonstrating the role of EMT in oral cancer and the extent to which it contributes to poor response to current therapeutic modalities. We will also examine the interplay between EMT and microRNAs and review the role of microRNAs in modulating resistance of oral cancer cells to current therapeutic modalities. Similarly, we will review how EMT contributes to the generation and maintenance of stem cells and examine the role of stem cells in oral cancer recurrence and in modulating treatment resistance. Finally, we will examine how EMT is involved in fibrosis, which can limit delivery of therapeutic agents to cancer cells. Overall, this review will summarize our understanding of how EMT contributes to oral cancer progression and identify additional therapeutic targets that may help to reduce the morbidity and mortality associated with oral cancer.
Keywords: Epithelial-mesenchymal transition, microRNA, stem cells, fibrosis, oral cancer, treatment resistance, chemotherapy, E-cadherin, metalloproteinas, cytokine interleukin
Current Cancer Therapy Reviews
Title: Understanding Epithelial-Mesenchymal Transition may Reveal Novel Therapeutic Targets for Oral Squamous Cell Carcinoma
Volume: 7 Issue: 2
Author(s): Hidayatullah G. Munshi and M. Sharon Stack
Affiliation:
Keywords: Epithelial-mesenchymal transition, microRNA, stem cells, fibrosis, oral cancer, treatment resistance, chemotherapy, E-cadherin, metalloproteinas, cytokine interleukin
Abstract: Worldwide more than 350,000 patients will be diagnosed with oral cancer this year; however, the survival of patients with oral cancer has not changed significantly over the last 30 years. Recent reports have demonstrated that epithelial-mesenchymal transition (EMT) not only contributes to cancer cell invasion and metastasis but it is also associated with treatment resistance. In this review, we will examine the data demonstrating the role of EMT in oral cancer and the extent to which it contributes to poor response to current therapeutic modalities. We will also examine the interplay between EMT and microRNAs and review the role of microRNAs in modulating resistance of oral cancer cells to current therapeutic modalities. Similarly, we will review how EMT contributes to the generation and maintenance of stem cells and examine the role of stem cells in oral cancer recurrence and in modulating treatment resistance. Finally, we will examine how EMT is involved in fibrosis, which can limit delivery of therapeutic agents to cancer cells. Overall, this review will summarize our understanding of how EMT contributes to oral cancer progression and identify additional therapeutic targets that may help to reduce the morbidity and mortality associated with oral cancer.
Export Options
About this article
Cite this article as:
G. Munshi Hidayatullah and Stack M. Sharon, Understanding Epithelial-Mesenchymal Transition may Reveal Novel Therapeutic Targets for Oral Squamous Cell Carcinoma, Current Cancer Therapy Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/1573394711107020104
DOI https://dx.doi.org/10.2174/1573394711107020104 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Challenges and Opportunities for Cancer Vaccines in the Current NSCLC Clinical Scenario
Current Topics in Medicinal Chemistry Development of Microfluidic-based Analytical Methodology for Studying the Effects of Chemotherapy Agents on Cancer Tissue
Current Analytical Chemistry Bispecific Antibodies: An Innovative Arsenal to Hunt, Grab and Destroy Cancer Cells
Current Pharmaceutical Biotechnology Rab GTPases, Membrane Trafficking and Diseases
Current Drug Targets Analytical Methods for the Identification of Pigments in Tattoo Inks and Some of Their Physiological Side Effects: A Review
Current Pharmaceutical Analysis Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
Current Cancer Therapy Reviews Aldose Reductase Enzyme and its Implication to Major Health Problems of the 21st Century
Current Medicinal Chemistry CSPG4 in Cancer: Multiple Roles
Current Molecular Medicine Differentiated Thyroid Carcinoma and Intestinal Polyposis Syndromes
Endocrine, Metabolic & Immune Disorders - Drug Targets Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma
Current Molecular Medicine Protective Effects of Downregulating Estrogen Receptor Alpha Expression in Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry Current Status Of Short Synthetic Peptides As Vaccines
Medicinal Chemistry Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects
Current Pharmaceutical Design Curcumin as an Adjuvant to Breast Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Imaging in the Age of Molecular Medicine: Monitoring of Anti-Angiogenic Treatments
Current Pharmaceutical Biotechnology The Complexities of TGF-β Action During Mammary and Squamous Cell Carcinogenesis
Current Pharmaceutical Biotechnology The mRNA-HPV Test Utilization in the Follow Up of HPV Related Cervical Lesions
Current Pharmaceutical Design Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Current Cancer Drug Targets Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation
Current Pharmaceutical Design Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification
Recent Patents on Anti-Cancer Drug Discovery